DiscoverBeginner's Mind#61: Bettina Resl, Sascha Berger,Tilmann Buerckstuemmer, Thomas Moser, Kimberly Cornfield - This was 2021 - A Year in Review Part 2/7
#61: Bettina Resl, Sascha Berger,Tilmann Buerckstuemmer, Thomas Moser, Kimberly Cornfield - This was 2021 - A Year in Review Part 2/7

#61: Bettina Resl, Sascha Berger,Tilmann Buerckstuemmer, Thomas Moser, Kimberly Cornfield - This was 2021 - A Year in Review Part 2/7

Update: 2022-01-08
Share

Description

Part 2 of the Year in Review Recording.

 1 hour 15 minutes of exciting conversations with speakers from previous podcast episodes and business partners of the hosts.

 What was hot in 2021, and what do our speakers expect for 2022?

In this episode, we talk about

  • Health Literacy and the Healthcare System
  • Venture Capital in 2021
  • Digitalization in Drug Development
  • The Golden Age of Biotech
  • Home Office – How Work-Life will Look like in the Post Pandemic World

I hope you enjoy the conversation the same way I did.

Who are the Experts in this episode:

Video to the Episode: https://youtu.be/HL-z1c_1XaU

Timestamps:
(02:00 ) Bettina Resl - Christmas Greetings
(03:11 ) Review of 2021  - Challenges for the Healthcare System in 2021 Beyond Covid 19
(06:32 ) Healthy Habits are the First Step to Longevity
(07:32 ) How Do Pharma Reach Patients?
(09:12 ) The Importance of Health Literacy – Concept and Strategies to Improve Health Literacy for the People
(16:56 ) What Happens to Home Office in a Post-Pandemic World
(20:00 ) Sascha Berger – Recap of 2021
(21:45 ) Significant closings in the Life Science VC world during the pandemic
(22:57 ) Lasting Effects of the Capital Flow Towards Life Science
(25:20 ) Will the Development Speed in the Pharma Industry in 2020/21 be Lasting?
(29:17 ) The Digital Revolution – Does it Affect the Dealflow of Life Science VCs?
(31:55 ) Outlook for 2022
(32:25 ) Conference Plans for 2022
(33:29 ) Thomas Moser and Tilmann Buerckstuemmer – Aelian Biotechnology
(35:33 ) Aelian Biotechnology – This was 2021
(36:00 ) Bit.BioDiscovery – Finding New Cell Types – The Holy Grail of Biology
(37:14 ) Outsourcing Trend for Pharma and Biotech Companies
(38:00 ) Trend to Digitalisation
(39:38 ) Data – Is it More Signal or More Noise?
(41:39 ) CRISPR - Trends
(42:40 ) The Golden Age of Biotech
(44:18 ) What is the Big Goal for The Holy Grail of Biology?
(46:34 ) Golden Age of Biotech or Bubble Territory?
(47:39 ) Increasing Health and Financial Literacy for the Common Good of Society
(48:18 ) Data Security in Gene Editing
(49:42 ) Paradigm Shift in Data Storage
(54:38 ) Outlook for 2022 – Aelian Biotech
(57:00 ) Astrid Wollard and Matthias Tarasiewicz – Recap of 2021
(58:51 ) Talent Shortage
(01:01:15 ) Web 2.0 vs. Web 3.0
(01:01:55 ) Use-Cases in Web 3.0 Beyond Token
(01:02:00 ) Kimberly Cornfield - Intro
(01:02:30 ) Research Activities at the UCL in Web 3.0 and Beyond
(01:04:00 ) European Research & Innovation at the UCL
(01:05:00 ) Effects of the Brexit on European Collaboration with British Universities
(01:07:00 ) How Did Collaborations between Universities Change With the Pandemic?
(01:08:29 ) Outlook for 2022 – Focused Research Areas
(01:10:20 ) Big Trends in Research in 2021
(01:11:00 ) Artificial Intelligence, Democracy, and Education
(01:11:48 ) Astrid Woollard – Potential of Artificial Intelligence
(01:13:00 ) Matthias Tarasiewicz – AI and Machine Learning in this decade
(01:15:32 ) Kimberly Cornfield – Horizon Europe 2022

Support the show (https://lsg2g.substack.com/subscribe?)
Comments 
In Channel
loading
Download from Google Play
Download from App Store
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

#61: Bettina Resl, Sascha Berger,Tilmann Buerckstuemmer, Thomas Moser, Kimberly Cornfield - This was 2021 - A Year in Review Part 2/7

#61: Bettina Resl, Sascha Berger,Tilmann Buerckstuemmer, Thomas Moser, Kimberly Cornfield - This was 2021 - A Year in Review Part 2/7

Christian Soschner